MedPath

Irritable Bowel Syndrome and Low FODMAP Diet

Not Applicable
Conditions
Irritable Bowel Syndrome
Registration Number
NCT02188680
Lead Sponsor
University Hospital, Rouen
Brief Summary

The patients having a syndrome SII would be more intolerant in the fructose than the healthy subjects and would benefit from a fructose diet but also from the fructans which contain some fructose. The intolerance in the fructose is diagnosed thanks to a respiratory test after absorption of fructose. However, the eviction of the fructose is sometimes recommended to the patients without having realized beforehand the test of intolerance.

Detailed Description

The main objective is to evaluate the efficacy of the FODMAPS diet on IBS symptoms and to correlate the results with the respiratory test

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
112
Inclusion Criteria
  • older than 18, patients with IBS, patients with no organic disorders, patients informed and agreed to participate
Exclusion Criteria
  • patients with sclerodermia, diabetes, obesity, anorexia, colo-rectal surgery, patients with small intestinal bacterial overgrowth, pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Fructose expiration rate (ppm)Day 15

Estimate the value of the fructose test to predict the efficiency of a diet excluding the fructose and its by-products on the digestive symptoms of the patients having a Syndrome of the irritable bowel.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Service de Physiologie Digestive, Urinaire, Respiratoire et Sportive

🇫🇷

Rouen, Haute Normandie, France

Service de Physiologie Digestive, Urinaire, Respiratoire et Sportive
🇫🇷Rouen, Haute Normandie, France
Anne-Marie LEROI, Professor
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.